Synthesis and biological evaluation of reversible inhibitors of IdeS, a bacterial cysteine protease and virulence determinant
- PMID: 19362485
- DOI: 10.1016/j.bmc.2009.03.026
Synthesis and biological evaluation of reversible inhibitors of IdeS, a bacterial cysteine protease and virulence determinant
Abstract
Analogues of the irreversible protease inhibitors TPCK and TLCK have been synthesized and tested as inhibitors of the bacterial cysteine protease IdeS excreted by Streptococcuspyogenes. Eight compounds were identified as inhibitors of IdeS in an in vitro assay. The most potent compounds contained an aldehyde function, thus acting as efficient reversible inhibitors, nitrile and azide derivatives showed moderate activity.
Similar articles
-
Enzymatic characterization of the streptococcal endopeptidase, IdeS, reveals that it is a cysteine protease with strict specificity for IgG cleavage due to exosite binding.Biochemistry. 2004 Dec 14;43(49):15540-9. doi: 10.1021/bi048284d. Biochemistry. 2004. PMID: 15581366
-
The serine protease inhibitors TLCK and TPCK react with the RB-binding core of HPV-18 E7 protein and abolish its RB-binding capability.Virology. 1996 Mar 15;217(2):542-53. doi: 10.1006/viro.1996.0149. Virology. 1996. PMID: 8610446
-
Proteinase inhibitors TPCK and TLCK prevent Entamoeba histolytica induced disturbance of tight junctions and microvilli in enteric cell layers in vitro.Int J Parasitol. 2004 Jun;34(7):785-94. doi: 10.1016/j.ijpara.2004.03.007. Int J Parasitol. 2004. PMID: 15157761
-
IdeS and SpeB: immunoglobulin-degrading cysteine proteinases of Streptococcus pyogenes.Curr Opin Microbiol. 2003 Feb;6(1):50-5. doi: 10.1016/s1369-5274(03)00003-1. Curr Opin Microbiol. 2003. PMID: 12615219 Review.
-
Non-peptidic inhibitors of cysteine proteases.Mini Rev Med Chem. 2003 Jun;3(4):361-73. doi: 10.2174/1389557033488079. Mini Rev Med Chem. 2003. PMID: 12678829 Review.
Cited by
-
Differential virulence gene expression of group A Streptococcus serotype M3 in response to co-culture with Moraxella catarrhalis.PLoS One. 2013 Apr 23;8(4):e62549. doi: 10.1371/journal.pone.0062549. Print 2013. PLoS One. 2013. PMID: 23626831 Free PMC article.
-
3-aminopiperidine-based peptide analogues as the first selective noncovalent inhibitors of the bacterial cysteine protease IdeS.J Med Chem. 2012 Mar 22;55(6):2549-60. doi: 10.1021/jm201517a. Epub 2012 Mar 14. J Med Chem. 2012. PMID: 22369147 Free PMC article.
-
Microbial and fungal protease inhibitors--current and potential applications.Appl Microbiol Biotechnol. 2012 Feb;93(4):1351-75. doi: 10.1007/s00253-011-3834-x. Epub 2012 Jan 5. Appl Microbiol Biotechnol. 2012. PMID: 22218770 Free PMC article. Review.
-
Streptococcal IdeS and its impact on immune response and inflammation.J Innate Immun. 2012;4(2):132-40. doi: 10.1159/000332940. Epub 2012 Jan 17. J Innate Immun. 2012. PMID: 22248585 Free PMC article. Review.
-
A comprehensive review on human disease-causing bacterial proteases and their impeding agents.Arch Microbiol. 2023 Jul 6;205(8):276. doi: 10.1007/s00203-023-03618-5. Arch Microbiol. 2023. PMID: 37414902 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources